Pigment Glaucoma: Triggers, Genetics, and Treatment

Pigment glaucoma, more formally called pigmentary glaucoma, is a type of secondary open-angle glaucoma caused by pigment granules shed from the back surface of the iris that clog the eye’s drainage system and raise internal eye pressure. It sits at the more severe end of a spectrum that begins with pigment dispersion syndrome, a condition in which pigment is released but eye pressure and the optic nerve remain normal. When that drainage obstruction becomes severe enough to damage the optic nerve or produce visual field loss, the diagnosis shifts to pigmentary glaucoma. The condition tends to strike younger, more nearsighted adults than most other forms of glaucoma, which makes early recognition especially important.

How Pigment Gets Loose in the First Place

The underlying problem is mechanical. In affected eyes, the iris bows backward toward the lens instead of sitting in its usual flat or slightly forward position. That backward bow pushes the pigmented layer on the back of the iris into contact with the bundles of fibers that hold the lens in place. Every time the pupil moves, those fibers scrape against the iris like a cheese grater, liberating tiny granules of melanin pigment into the fluid that circulates through the front of the eye.¹ The fluid carries those granules forward, and they settle onto various structures: the inner surface of the cornea, the lens capsule, and, most critically, the trabecular meshwork, which is the sieve-like tissue responsible for draining fluid out of the eye.

When pigment granules accumulate in the trabecular meshwork, the cells lining it try to clean up by engulfing the debris. Laboratory work on these meshwork cells shows that the cleanup effort backfires. After exposure to pigment particles, the cells’ ability to engulf material dropped by nearly half within a single day. The pigment triggers a signaling cascade that stiffens the cells, increases their internal tension, and actually inhibits further cleanup.² Over months and years, this creates a vicious cycle: more pigment accumulates, the meshwork becomes progressively less efficient at draining fluid, and intraocular pressure climbs.

The Three Classic Signs

Clinicians look for a well-known triad when they suspect pigment dispersion. The first is spoke-like transillumination defects in the mid-periphery of the iris, visible when a slit-lamp beam is shone through the eye. These radial gaps appear where pigment has been rubbed away. The second is a Krukenberg spindle, a vertical streak of pigment deposited on the inner surface of the cornea, shaped like a spindle because convection currents in the eye’s fluid naturally sort the particles that way. The third is a densely and uniformly pigmented trabecular meshwork, visible during a gonioscopy exam, where the doctor uses a special lens to view the drainage angle.³ Not every patient will have all three signs, but finding two of the three in the same eye is enough to make the diagnosis of pigment dispersion syndrome.⁴

The distinction between pigment dispersion syndrome and pigmentary glaucoma hinges on whether the pigment buildup has caused measurable harm. A person whose eye pressure, optic nerve, and visual fields all remain normal has pigment dispersion syndrome. Once pressure climbs above the normal range, or the optic nerve shows damage, or visual field testing reveals blind spots, the label changes to pigmentary glaucoma.

Who Gets It

The typical profile is a young to middle-aged man with moderate to high myopia and lighter eye color, though the condition can affect women and people of any race. Pigment dispersion syndrome and pigmentary glaucoma are recognized as two stages on the same disease spectrum, with racial differences in both prevalence and progression. The conversion rate from pigment dispersion to frank glaucoma is roughly a third in white populations and appears to be even higher in Black and Asian populations, who often require more aggressive monitoring and treatment.⁵ A separate long-term follow-up study found somewhat lower conversion rates when measured over time: about 10% at five years and 15% at fifteen years. In that study, the single strongest predictor of progression was having elevated eye pressure at the initial visit, while age, degree of nearsightedness, and family history of glaucoma did not predict who would convert.⁶

The spread between these estimates is worth noting. Some sources place the lifetime risk of developing glaucoma from pigment dispersion as high as 35 to 50 percent.⁷ The differences partly reflect how strictly each study defines “glaucoma,” how long patients were followed, and whether the study population was recruited from specialty clinics (where more severe cases cluster) or from general ophthalmology practices. The practical takeaway is that pigment dispersion syndrome is not a benign curiosity: a meaningful fraction of people who have it will go on to develop pressure-related optic nerve damage if they are not monitored regularly.

Genetics and Heritability

Pigment dispersion runs in families. A study that examined first-degree relatives of affected patients found that about one in ten of them also met diagnostic criteria for the syndrome, and the majority of those affected family members already showed moderate to heavy pigmentation of the trabecular meshwork.⁸ Genetic mapping has linked the condition to a region on chromosome 7 in families with an autosomal dominant pattern, and researchers have identified mutations in the PMEL gene (which encodes a protein involved in pigment granule formation) in multiple affected families.⁹ More recent genome-wide studies have flagged additional susceptibility loci, including regions near genes called GSAP and GRM5/TYR.¹⁰

The involvement of PMEL is particularly interesting because the same gene is already well known in animal models for its role in melanin biology. In humans, the mutations found so far are relatively rare coding changes rather than common variants, which partly explains why large-scale genetic screening has not yet become a routine clinical tool for this condition. Still, the family clustering means that if you are diagnosed with pigment dispersion syndrome, it is worth mentioning it to blood relatives so they can be checked.

Exercise and Other Triggers for Pigment Showers

One of the more unusual features of pigmentary glaucoma is that physical activity can provoke acute episodes. Vigorous exercise causes the pupil to dilate and constrict rapidly, which accelerates the mechanical scrubbing of pigment from the iris. A classic case report described a young man with pigment dispersion syndrome who experienced blurred vision and halos around lights after strenuous exercise. Examination showed a fresh shower of pigment in the front of his eye along with a spike in eye pressure. The same patient also had symptoms triggered by emotional stress and dim lighting, both of which cause the pupil to dilate.¹¹

This does not mean that people with pigment dispersion should avoid exercise. Regular physical activity is beneficial for overall health and even for long-term eye pressure control. But it does mean that episodes of sudden blurry vision, halos, or eye discomfort after a hard workout should be reported to an eye doctor rather than shrugged off. In someone already known to have pigment dispersion, such episodes may signal pressure spikes that need to be managed. Some clinicians advise patients at risk to use their pressure-lowering eye drops shortly before intense exercise as a precaution, though this is individualized rather than a blanket recommendation.

Imaging the Problem

The backward bowing of the iris that drives pigment release can be directly visualized with high-frequency ultrasound imaging of the front of the eye, a technique called ultrasound biomicroscopy. In a study of patients with asymmetric disease (one eye worse than the other), the more affected eye consistently showed a more concave iris configuration and greater contact between the iris and the lens, while lens thickness and eye length were no different between the two eyes.¹² This finding supports the idea that the shape of the iris itself, not the size of the eye or the lens, is the critical anatomical risk factor.

Anterior segment optical coherence tomography, a non-contact imaging method, can also show the relationship between the iris and nearby structures. It has been used alongside ultrasound to document pigment-related problems that arise after certain types of lens implant surgery, where the edge of an artificial lens can rub against the back of the iris in the same way that natural lens fibers do in the primary disease.¹³ This form of “secondary” pigmentary glaucoma after cataract surgery is an important reminder that the mechanism can be triggered by anything that creates friction against the back of the iris.

Treatment Options

The first line of treatment for elevated eye pressure in pigmentary glaucoma is the same as for other forms of open-angle glaucoma: topical pressure-lowering drops. Prostaglandin analogs, beta-blockers, and alpha-agonists are all used. Because pigmentary glaucoma tends to affect younger patients, tolerability and side effects matter more over what may be decades of treatment. Miotics, which constrict the pupil, have a theoretical advantage because they pull the iris forward and reduce mechanical contact with the lens. In practice, however, the blurred near vision and dim lighting that miotics cause make them unpopular among younger, active patients.

Laser peripheral iridotomy, a procedure that creates a tiny hole in the iris to equalize pressure between the front and back chambers of the eye, addresses the root cause by flattening the iris and stopping the backward bow. A ten-year randomized trial found striking results in high-risk patients (those whose eye pressure was already elevated). Among treated high-risk eyes, only about 14% saw a meaningful pressure increase over the follow-up period, compared with roughly 62% of untreated high-risk eyes. The average time before a pressure event occurred was about eight years in the treated group versus under four years in the untreated group.¹⁴ A separate, shorter trial, however, found no benefit from the same laser procedure over three years in patients who had pigment dispersion with elevated pressure but not yet frank glaucoma.¹⁵ The discrepancy likely comes down to follow-up length and patient selection: the benefit of flattening the iris may take years to become apparent, and it may matter most in the patients already on the steeper trajectory toward glaucoma.

When drops and laser therapy are not enough, surgery enters the picture. Trabeculectomy, which creates a new drainage pathway for fluid to leave the eye, and minimally invasive glaucoma surgeries are both used. A large comparative analysis found that pigmentary glaucoma patients had somewhat higher one-year failure rates after laser trabeculoplasty and minimally invasive procedures compared with patients who had primary open-angle glaucoma. Combined trabeculectomy with cataract surgery also fared worse than stand-alone trabeculectomy in both groups.¹⁶ The higher failure rates do not mean surgery should be avoided; rather, they inform the choice of procedure and the intensity of postoperative follow-up.

How Visual Field Loss Differs

Glaucoma damages the optic nerve, and the pattern of resulting blind spots in the visual field can vary by type. In pigmentary glaucoma, the pattern of field loss is broadly similar to primary open-angle glaucoma but with some distinguishing features. A comparison study found that primary open-angle glaucoma patients tended to have more severe damage in the temporal portions of the visual field, whereas pigmentary glaucoma patients were relatively spared in those areas.¹⁷ The practical significance is limited for most patients, since the treatments are similar, but the difference can help a clinician distinguish pigmentary from other forms of glaucoma when the physical signs are ambiguous.

The “Burnout” Phenomenon

One of the more counterintuitive aspects of pigmentary glaucoma is that pigment shedding tends to slow down with age. As a person gets older, the lens thickens and pushes the iris forward, reducing the backward bow that causes mechanical friction. The Krukenberg spindle may fade, the trabecular meshwork may gradually depigment, and transillumination defects can become less obvious. Clinicians sometimes call this the “burnt-out” phase. It can be misleading, because a doctor seeing the patient for the first time in this later stage may not recognize the underlying cause of the glaucoma. The optic nerve damage and elevated pressure may persist even as the pigment-shedding source winds down, because the trabecular meshwork has already been structurally damaged from years of pigment overload.

This burnout effect also complicates long-term studies of the condition. Patients who appear to “stabilize” in their fifties or sixties may simply have transitioned from active pigment release to a phase where the damage is done but the visible signs have faded. Continued monitoring is still essential, because the drainage system does not fully recover.

Pigmentary Glaucoma in Children

Pigment dispersion syndrome and pigmentary glaucoma are overwhelmingly diseases of young to middle-aged adults, but rare pediatric cases exist. The youngest reported case of typical pigment dispersion involved an eight-year-old boy, who had the classic signs on examination but normal eye pressures.¹⁸ In a separate family, a child presented with severe bilateral pigmentary glaucoma complete with Krukenberg spindles, deep anterior chambers, and heavily pigmented drainage angles. Strikingly, both of his siblings also had pigment dispersion syndrome, which was diagnosed through specialized angle examination.¹⁹

These cases are important for two reasons. First, they reinforce the genetic component: when pigment dispersion shows up in a child, the family history is almost always telling. Second, they highlight that glaucoma in children is easy to miss. A child is unlikely to complain about gradual peripheral vision loss, and routine school vision screenings do not measure eye pressure or examine the drainage angle. Pediatricians and parents should be aware that a family history of pigment dispersion syndrome warrants a comprehensive eye exam for children in that family, even in the absence of symptoms.

Secondary Pigmentary Glaucoma After Eye Surgery

The same mechanical principle that drives primary pigmentary glaucoma can be replicated by artificial structures inside the eye. After cataract surgery, the edge of an intraocular lens implant can sit close enough to the back of the iris to rub against its pigmented layer, producing a secondary form of pigment dispersion. Anterior segment imaging has confirmed close contact between the implant edge and the posterior iris epithelium in such cases.²⁰ This secondary form can develop months to years after an otherwise successful cataract procedure, so any new onset of elevated pressure, pigment on the cornea, or visual symptoms in a post-cataract patient should prompt evaluation for this possibility. In some cases, exchanging the implant for a different design or size resolves the problem. In others, pressure-lowering treatment or surgery is needed, just as in the primary disease.